Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies

被引：93

作者：

Moody, M. Anthony ^{[1
,2
,3
]}

Pedroza-Pacheco, Isabela ^{[4
]}

Vandergrift, Nathan A. ^{[1
,5
]}

Chui, Cecilia ^{[4
]}

Lloyd, Krissey E. ^{[1
]}

Parks, Robert ^{[1
]}

Soderberg, Kelly A. ^{[1
]}

Ogbe, Ane T. ^{[4
]}

Cohen, Myron S. ^{[6
]}

Liao, Hua-Xin ^{[1
,5
]}

Gao, Feng ^{[1
,5
]}

McMichael, Andrew J. ^{[4
]}

Montefiori, David C. ^{[7
]}

Verkoczy, Laurent ^{[1
,5
,8
]}

Kelsoe, Garnett ^{[1
,2
]}

Huang, Jinghe ^{[9
]}

Shea, Patrick R. ^{[10
]}

Connors, Mark ^{[9
]}

Borrow, Persephone ^{[4
]}

Haynes, Barton F. ^{[1
,2
,5
]}

机构：

[1] Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA

[2] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA

[3] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27710 USA

[4] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7FZ, England

[5] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA

[6] Univ North Carolina Chapel Hill, Chapel Hill, NC 27599 USA

[7] Duke Univ, Sch Med, Dept Surg, Durham, NC 27710 USA

[8] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA

[9] NIAID, Lab Immunoregulat, NIH, Bethesda, MD 20814 USA

[10] Columbia Univ, Inst Genom Med, New York, NY 10032 USA

来源：

SCIENCE IMMUNOLOGY | 2016年 / 1卷 / 01期

关键词：

T FOLLICULAR HELPER; SIMIAN IMMUNODEFICIENCY VIRUS; B-CELL ACTIVATION; GERMINAL CENTER; ENVELOPE GLYCOPROTEINS; HIV-1; INFECTION; RHESUS MACAQUES; RESPONSES; TOLERANCE; REGION;

D O I：

10.1126/sciimmunol.aag0851

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Induction of broadly neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development. bnAbs occur in some HIV-1-infected individuals and frequently have characteristics of autoantibodies. We have studied cohorts of HIV-1- infected individuals who made bnAbs and compared them with those who did not do so, and determined immune traits associated with the ability to produce bnAbs. HIV-1-infected individuals with bnAbs had a higher frequency of blood autoantibodies, a lower frequency of regulatory CD4(+) T cells, a higher frequency of circulating memory T follicular helper CD4(+) cells, and a higher T regulatory cell level of programmed cell death-1 expression compared with HIV-1-infected individuals without bnAbs. Thus, induction of HIV-1 bnAbs may require vaccination regimens that transiently mimic immunologic perturbations in HIV-1-infected individuals.

引用

页数：10

共 50 条

[21] Trispecific broadly neutralizing antibodies for HIV immunoprophylaxis and immunotherapy?
Barin, Francis
Stefic, Karl
M S-MEDECINE SCIENCES, 2018, 34 (02): : 109 - 111
[22] Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Ahmed, Yousuf
Tian, Meijuan
Gao, Yong
AIDS RESEARCH AND THERAPY, 2017, 14
[23] Development of screening assays for use of broadly neutralizing antibodies in people with HIV
Lynch, Rebecca M.
Bar, Katharine J.
CURRENT OPINION IN HIV AND AIDS, 2023, 18 (04) : 171 - 177
[24] Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Stephenson, Kathryn E.
Wagh, Kshitij
Korber, Bette
Barouch, Dan H.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38, 2020, 38 : 673 - 703
[25] Use of broadly neutralizing antibodies for HIV-1 prevention
Pegu, Amarendra
Hessell, Ann J.
Mascola, John R.
Haigwood, Nancy L.
IMMUNOLOGICAL REVIEWS, 2017, 275 (01) : 296 - 312
[26] Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy
Yilmaz, Aylin
Price, Richard W.
Spudich, Serena
Fuchs, Dietmar
Hagberg, Lars
Gisslen, Magnus
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (02) : 168 - 173
[27] HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies
Serwanga, Jennifer
Ssemwanga, Deogratius
Muganga, Michael
Nakiboneka, Ritah
Nakubulwa, Susan
Kiwuwa-Muyingo, Sylvia
Morris, Lynn
Redd, Andrew I.
Quinn, Thomas C.
Kaleebu, Pontiano
VACCINE, 2018, 36 (04) : 578 - 586
[28] Immune reconstitution in HIV-1-infected individuals treated with potent antiretroviral therapy
Connick, E
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2001, 6 (03) : 212 - 218
[29] EFFECT OF PURIFIED IGGS FROM HIV-1-INFECTED AND NON INFECTED INDIVIDUALS ON IMMUNE ACTIVATION
CHAMS, V
BIOU, D
CHO, YY
MBIKA, JP
LECOQ, H
HESHMATI, F
FOUCHARD, M
BIZZINI, B
ZAGURY, JF
BIOMEDICINE & PHARMACOTHERAPY, 1994, 48 (5-6) : 267 - 272
[30] Broadly Neutralizing Antibodies and their Significance for HIV-1 Vaccines
Gonzalez, Nuria
Alvarez, Amparo
Alcami, Jose
CURRENT HIV RESEARCH, 2010, 8 (08) : 602 - 612

← 1 2 3 4 5 →